BELOTERO®

Find the Right Belotero®: Which Gel Belongs in Which Zone

Choosing a Belotero® dermal filler begins with the treatment area and the intended depth of correction. Firmer gels may be suited to deeper support, while softer formulations are used for more superficial concerns. The map below offers a starting point for product selection:

• Upper face and under the eyes: Soft for fine superficial lines, Balance for the periorbital hollow
• Midface: Volume
• Nasolabial folds and marionette lines: Balance, or Intense where local labeling allows
• Lips: Intense (+) in the US; Lips Shape and Lips Contour in markets where they are CE-marked
• Neck: Soft, kept very superficial

The treatment map does not replace product-specific labeling. Before you order Belotero® online, review the intended indication, formulation, and lidocaine content for your market.

The Belotero® Range Compared: Gel Strength, Depth and Lidocaine

The table compares six Belotero® presentations by HA concentration, treatment depth, and lidocaine status for those looking to buy Belotero® products. For example, a practice preparing to buy Belotero® Soft needs to confirm whether the available formulation matches its intended use and local labeling.

Belotero® fillers use Cohesive Polydensified Matrix (CPM®) technology, which gives the gels different characteristics suited to their intended treatment areas. The US-approved Balance (+), Volume (+), and Intense (+) formulations contain lidocaine, while presentations in other markets may differ.

Beyond the six products compared above, the range includes Belotero® Revive, which combines cross-linked hyaluronic acid with glycerol, and Belotero® Hydro, which contains non-cross-linked hyaluronic acid and glycerol for hydration.

Upper Face: Tear Troughs, Crow’s Feet and Forehead Lines

For under-eye hollowing, Belotero® Balance (+) is FDA-approved for adults over 21. Treatment suitability depends on the patient’s anatomy, tissue characteristics, and clinical assessment. The thin skin and complex vascular anatomy around the eyes make careful product selection and adherence to the approved injection technique especially important.

Hyaluronic acid filler placed too superficially beneath the eyes can cause a bluish Tyndall effect. Treatment requires careful patient assessment and adherence to the injection planes and precautions in the relevant product’s labeling. US Balance (+) and non-US presentations may have different instructions.

Belotero® Soft may be considered for superficial crow’s feet and static forehead lines where local labeling permits. Its softer formulation is suited to selected fine-line concerns, while a neuromodulator may be used separately to address the underlying muscle activity.

Cheeks, Folds and Chin: Build Support Before Smoothing Lines

Belotero® Volume (+) is FDA-approved for deep subcutaneous and/or supraperiosteal injection to improve midface volume deficits or contour deficiencies in adults 22 and older. Merz reports correction lasting up to 18 months and 95% patient satisfaction at 12 weeks.[5] In the US pivotal study, participants were followed to week 48 before optional repeat treatment; later follow-up visits should not be interpreted as proof that a single treatment lasted 72 weeks without retreatment.[4] Individual results vary.

When midface volume loss contributes to facial folds, restoring support may reduce the need for direct correction. Belotero® Balance (+) is FDA-approved for moderate-to-severe facial wrinkles and folds, including nasolabial folds. Treatment of other areas must follow the applicable product labeling.

A 108-patient multicenter study of lidocaine-containing Belotero® gels reported using an Intense-type formulation for nasolabial folds with deep-dermal placement.[1] Clinics intending to buy Belotero® Intense for fold correction should not interpret this study as FDA authorization for that use of US Intense (+), which is approved for lip augmentation. Chin treatment with Volume also depends on local labeling.

Lips, Perioral Lines and the Neck

In the US, Belotero® Intense (+) Lidocaine is FDA-approved for lip augmentation in adults older than 21.[3] In the pivotal study, 91.1% of participants achieved the specified lip-fullness improvement at week eight, and 48.7% met the criterion at week 48.[3] A touch-up was permitted at week four. These study outcomes do not guarantee the same degree or duration of correction for every patient.

Outside the US, Lips Shape and Lips Contour work as a pair: Shape builds volume in the body of the lip, while Contour defines the vermilion border. Both come in 0.6 mL single-use syringes, allowing practitioners to choose a presentation suited to the planned correction. Any unused product must be handled according to the manufacturer’s single-use instructions.

For fine perioral lines, the choice between Soft and Lips Contour depends on the locally authorized indications and tissue depth. The cited multicenter study evaluated lidocaine-containing Belotero® gels in several facial regions, including perioral areas.[1] Belotero® Soft may be used for superficial neck and décolletage lines where the relevant IFU permits it.

Patient Selection and Preparing for a Belotero® Injection

Patient assessment should guide the choice of Belotero® formulation. A good candidate is an adult with fine-to-moderate lines, thin or delicate skin, tear-trough hollowing, or lip and midface volume loss, who has realistic expectations. The assessment covers skin thickness, the degree of volume loss, lip proportions, and the patient’s goals. Age limits are product-specific in the US: over 21 for Balance (+) in the infraorbital hollow and for Intense (+) in the lips, and 22 or older for Volume (+) in the midface.

Contraindications and precautions vary by formulation. US labeling identifies severe allergies, including a history of anaphylaxis, and known hypersensitivity to product components as contraindications. Lidocaine-containing formulations must not be used in patients allergic to lidocaine or related anesthetics. Patients prone to excessive scarring or keloids may also be unsuitable. Treatment should be deferred when active infection or inflammation is present at the injection site. Pregnancy, breastfeeding, immunosuppressive therapy, bleeding disorders, and anticoagulant use require additional consideration according to the relevant product labeling.

To prepare for a Belotero® injection, take baseline photographs, document consent, and review medications and supplements that raise bruising risk. Use a topical anesthetic where the product contains no lidocaine. Because intravascular injection is the most serious risk, Merz advises that practitioners may check vision before and after treatment and know in advance which eye specialist to call.

How Long Does Belotero® Last? Results and Review Timing, Product by Product

Correction is visible immediately, although swelling can affect the initial appearance. A review at two to four weeks lets clinicians assess the result and decide whether further treatment is appropriate. Duration depends on the product and the area, so no single brand-wide figure applies. Based on Merz data:

Individual results vary with patient anatomy, treatment area, and the amount injected. Maintenance schedules should reflect the response in each treated zone rather than assume that lips, fine lines, and midface correction require the same follow-up interval.

Handling Complications: Vascular Occlusion, Tyndall Effect and Nodules

Vascular occlusion is uncommon but can cause skin necrosis, vision loss, or stroke. Warning signs include sudden blanching, disproportionate pain, livedo-like discoloration, and visual or neurological symptoms. If vascular compromise is suspected, stop injecting and activate an established emergency protocol immediately, including prompt consideration of hyaluronidase for hyaluronic acid-related ischemia.

Early recognition and treatment are critical; suspected vascular compromise should never be managed with a wait-and-see approach.[2] Sudden visual changes or neurological symptoms require emergency assessment and specialist escalation.

The Tyndall effect and some hyaluronic acid-related nodules may respond to hyaluronidase after appropriate clinical assessment. Persistent swelling and delayed inflammatory reactions require evaluation of the underlying cause and may need additional treatment. Not every complication is fully reversible, especially after vascular injury.

Delayed-onset inflammation can follow illness, vaccination, or dental work and typically responds to treatment or resolves on its own. Keep hyaluronidase in stock wherever you inject, and agree on an escalation plan with a local eye specialist before you need it.

Belotero® Approvals: What the FDA and CE Mark Each Cover

• Balance (+): FDA-approved for moderate-to-severe facial wrinkles and folds, such as nasolabial folds, and for infraorbital-hollow volume augmentation in adults over 21. Belotero® Balance (+) is the lidocaine-containing US formulation.
• Volume (+): The FDA approved this lidocaine-containing formulation on May 19, 2026, for deep injection to correct midface volume or contour deficiencies in adults aged 22 and older.[4] Merz announced the approval on September 14, 2026, with an anticipated US launch of October 14, 2026; current supplier availability should be confirmed separately.[5]
• Intense (+): The FDA approved this lidocaine-containing formulation on July 9, 2026, for lip augmentation in adults over 21.[3] Merz announced the approval publicly on September 14, with US commercial availability projected from December 1, 2026.[5]
• Soft, Lips Shape, Lips Contour, Revive and Hydro: CE-marked, not FDA-approved.

FDA approvals apply to specific formulations and indications. For clinics seeking to buy Belotero® Balance for US infraorbital treatment, the authorized presentation is Balance (+) Lidocaine—not every product bearing the Balance name. CE marking does not establish US approval, and published launch dates do not confirm supplier stock.

Belotero® Filler Price: How to Buy Belotero® Wholesale

Belotero® filler price depends on formulation, syringe size, and the amount used per procedure. Comparing Belotero® cost by treatment area gives clinics a clearer picture of the Belotero® price offered by the Belotero® supplier, than relying on one price for the entire range.

Lidocaine content and regional packaging can also affect Belotero® filler cost. A Belotero® Intense price comparison should distinguish the US (+) Lidocaine presentation from other versions.

Under Medica Depot’s group buy programme, eligible Balance, Intense, and Volume orders may qualify for Belotero® at wholesale prices. Licensed practices looking to buy Belotero® wholesale can request a quote specifying the presentations, quantities, and unit prices.

Stock planning calls for more than a discounted unit price. When clinics order Belotero® wholesale for recurring supply, confirmed lead times and product expiry dates help determine a practical replenishment schedule.

Zone-by-Zone: How Belotero® Compares With Other Fillers

STYLAGE® (Vivacy)

STYLAGE S and M contain mannitol and are marketed for selected superficial-line indications. They can be evaluated alongside Belotero® Soft and Balance, with attention to differences in texture, regional labeling, and intended use. These particular STYLAGE presentations are marketed in European markets; US authorization should not be assumed.

SAYPHA® (Croma)

SAYPHA Filler can be compared with Belotero® Intense for selected facial-fold treatments, while SAYPHA® Rich and Belotero® Revive address skin-quality concerns. Differences in formulation, approved indications, and regional availability should guide selection rather than price alone.

TEOSYAL® (Teoxane)

For dynamic perioral areas, TEOSYAL RHA KISS and RHA 2 offer points of comparison with Belotero® Intense (+) and Balance (+). Formulation properties and authorized injection sites differ, so the products should not be treated as direct substitutes.

REVANESSE® (Prollenium)

REVANESSE Lips+ and Belotero® Intense (+) are both options for lip augmentation in markets where they are authorized. Their gel structures differ: REVANESSE uses relatively uniform particles, while Belotero® uses a cohesive polydensified matrix.

JUVÉDERM® (AbbVie)

In the midface, JUVÉDERM VOLUMA® can be compared with Belotero® Volume (+), while VOLBELLA® offers another consideration for under-eye correction when used according to its approved labeling.

RESTYLANE® (Galderma)

RESTYLANE Eyelight is another option for under-eye hollow correction, while Kysse and Lyft address lip augmentation and cheek volume, respectively. These products can be compared with Belotero® Balance (+), Intense (+), and Volume (+) by facial zone, but selection must follow each product’s approved indications and regional labeling.

Where to Buy Belotero® Online From a Verified Supplier

Medica Depot supplies Belotero® to licensed medical professionals. Listings of Belotero® for sale should identify the Merz Aesthetics presentation and intended market, supported by original packaging, traceable lot numbers, and expiry details.

Verified accounts can order Belotero® online through the catalogue. For larger or recurring purchases, the team can also confirm stock, group buy eligibility, and shipping dates before clinics order Belotero® wholesale.

Once the presentation and delivery terms are confirmed, licensed professionals can purchase Belotero® by adding the selected products to their cart. Medica Depot’s team can also assist with larger orders.

FAQs

Is the hyaluronic acid in Belotero® animal-derived?

No. Belotero® uses hyaluronic acid of non-animal origin, produced through bacterial fermentation. Many of its dermal fillers contain HA cross-linked with BDDE, while formulations such as Hydro use non-cross-linked HA. Practitioners should also screen for relevant allergies, including hypersensitivity to residual bacterial proteins, as specified in the product’s labeling before they order Belotero®.

Who is a good candidate for Belotero® treatment?

A suitable candidate is an adult whose treatment goals match the chosen product’s approved indications, with appropriate anatomy, realistic expectations, and no relevant contraindications. Patient selection is especially important for under-eye, lip, and midface procedures.

What should patients avoid before and after Belotero® injections?

Before treatment, patients should disclose prescription medications, over-the-counter drugs, and supplements that may increase bruising or bleeding. Patients should never discontinue prescribed anticoagulants or antiplatelet medications without guidance from the prescribing clinician. After treatment, patients should follow the product-specific instructions regarding exercise, heat exposure, alcohol, and care of the injection site.

Can Belotero® be used on the décolletage or hands?

Certain Belotero® formulations may be used for selected superficial lines or skin-quality concerns in the décolletage, depending on their regional labeling. Practitioners considering hand treatment should review the product’s IFU, as an indication approved in one market may not apply elsewhere.

When can a Belotero® touch-up be done?

Clinicians commonly schedule a follow-up assessment two to four weeks after treatment, once initial swelling has subsided. The need for a touch-up depends on the product, treatment area, and clinical response. In the Intense (+) lip study, touch-ups were permitted at week four.

How should unopened Belotero® syringes be stored?

Follow the product-specific label. US labeling for Belotero® Balance (+) specifies storage at room temperature up to 25°C, away from heat, and says not to freeze the syringe. Other Belotero® formulations may have different storage requirements.

What is Belotero® Revive, and how does it differ from the fillers?

Belotero® Revive combines cross-linked hyaluronic acid with glycerol to address skin hydration and quality. Unlike volumizing formulations, it focuses on more superficial concerns rather than restoring facial volume. Approved uses vary by region.

The contents of this page are meant for licensed medical professionals. They serve informational purposes only and are not to be taken as medical advice.

Citations

[1] Kühne, Ulrich et al. “Safety and performance of cohesive polydensified matrix hyaluronic acid fillers with lidocaine in the clinical setting – an open-label, multicenter study.” Clinical, cosmetic and investigational dermatology vol. 9 373-381. 20 Oct. 2016, doi:10.2147/CCID.S115256

[2] Cohen, Joel L et al. “Treatment of Hyaluronic Acid Filler-Induced Impending Necrosis With Hyaluronidase: Consensus Recommendations.” Aesthetic surgery journal vol. 35,7 (2015): 844-9. doi:10.1093/asj/sjv018

[3] U.S. Food and Drug Administration. “Summary of Safety and Effectiveness Data (SSED): BELOTERO INTENSE® (+) Lidocaine (P250016).” U.S. Food and Drug Administration, 9 July 2026, www.accessdata.fda.gov/cdrh_docs/pdf25/P250016B.pdf.

[4] U.S. Food and Drug Administration. “Summary of Safety and Effectiveness Data (SSED): BELOTERO VOLUME® (+) (P250020).” U.S. Food and Drug Administration, 19 May 2026, www.accessdata.fda.gov/cdrh_docs/pdf25/P250020B.pdf.

[5] Merz Aesthetics. “Merz Aesthetics® Brings Comprehensive BELOTERO® Hyaluronic Acid Portfolio to U.S. Market with FDA Approvals of BELOTERO VOLUME® (+) and BELOTERO INTENSE® (+).” Business Wire, 14 Sept. 2026, www.businesswire.com/news/home/20260914841148/en/Merz-Aesthetics-Brings-Comprehensive-BELOTERO-Hyaluronic-Acid-Portfolio-to-U.S.-Market-with-FDA-Approvals-of-BELOTERO-VOLUME-and-BELOTERO-INTENSE-.